研究子宫内膜异位症和不良妊娠结果之间的相关性
Qiao-Hong Dai1, Hai-Rui Cai1, An-Er Chen1
1Department of Gynecology and Obstetrics, Women and Children's Hospital Affiliated to Ningbo University, Ningbo 315000, Zhejiang Province, China.
概括
有子宫内膜异位症 (EMS) 的怀孕与不良产科结果的风险增加有关,包括胎盘前出血和产后出血. 这凸显了在管理这些怀孕时需要更大的临床意识的需要.
科学领域:
- 产科和妇科 产科和妇科
- 生殖医学 生殖医学
- 临床流行病学临床流行病学
背景情况:
- 子宫内膜异位症 (EMS) 是一种影响生育年龄妇女的疾病.
- 关于EMS对怀孕和产科结果的影响需要进一步研究.
研究的目的:
- 调查子宫内膜异位症和不良产科结果之间的相关性.
- 为了比较怀孕后果在女性和没有子宫内膜异位症.
主要方法:
- 对2925例剖腹产病例的回顾性分析.
- 对1363名患有子宫内膜异位症的妇女 (研究组) 和1562名没有子宫内膜异位症的妇女 (对照组) 的比较.
- 评估母亲的年龄,平价,妊娠年龄,ART使用,自发流产,早产,胎盘前,胎盘粘附和产后出血.
主要成果:
- 患有子宫内膜异位症的女性平均产妇年龄较高,怀孕/分娩次数较少,妊娠年龄较短.
- 在子宫内膜异位症组中观察到初级不孕症,自发流产和ART使用率的增加.
- 在患有子宫内膜异位症 (P <0.05) 的妇女中,发现有较高的胎盘前期,胎盘粘附和产后出血率.
结论:
- 患有子宫内膜异位症的女性的怀孕与不良产科结果的可能性更高有关.
- 这些发现强调了提高临床警和专业照顾EMS孕妇的必要性.
- 早期识别和管理策略可以减轻怀孕期间与子宫内膜异位症相关的风险.
更多相关视频
07:20Intraoperative Detection of Subtle Endometriosis: A Novel Paradigm for Detection and Treatment of Pelvic Pain Associated with the Loss of Peritoneal Integrity
Published on: December 21, 2012
15.9K
11:29Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma
Published on: January 22, 2022
14.1K
相关概念视频
Oogenesis
63.6K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.6K
Ovarian Cycle
1.1K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
1.1K
Disorders of the Female Reproductive System
347
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
347
Teratogenicity
2.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K
Meiosis vs. Mitosis
55.1K
Cell division is necessary for growth and reproduction in organisms. Mitosis aids cell growth and development by dividing somatic cells. In contrast, meiosis causes the division of germ cells and plays an essential role in sexual reproduction. Due to their unique functional requirements, mitosis and meiosis differ from each other in multiple aspects.
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
55.1K
Hormonal Regulation of the Menstrual Cycle
339
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
339
